And can ring a few registers, too. In the UK, more than a million people will be put on statins to lower their cholesterol level and prevent heart attacks, under new guidelines published today. Docs are urged to trawl the records of patients aged 40 and over to find people with a one in five chance of having a heart attack or stroke and call them in for advice and drugs, The Telegraph reports.
Four million people already take statins, mostly after heart attacks. But the UK’s National Institute for Health and Clinical Excellence wants healthy people deemed at high risk of an attack or a stroke within 10 years to have preventive drugs as well, the paper writes. That would put 1.5 million more on meds and should prevent an extra 15,000 heart attacks, strokes and new cases of angina each year.
NICE recommends checking records of everyone aged between 40 and 75 to flag those at high risk and call them in for lifestyle advice and consider prescribing 40mg of generic Zocor. Putting healthy people on meds for the rest of their lives may be controversial, but some docs say the move is worthwhile.
Tim Marshall, a public health specialist and member of the NICE guideline development group, says that “cardiovascular disease is the leading cause of death in England and Wales, accounting for 124,000 deaths – one in three – in 2005. For every one fatality there are at least two people who have a major non-fatal cardiovascular event. The guideline suggests an achievable and realistic strategy for identifying those people at high risk.”
Peter Weissberg of the British Heart Foundation gave a mixed reaction: “The BHF welcomes NICE’s endorsement that cardiovascular risk factors should be identified and adapted for each patient. However, relying on patients to attend surgeries for assessment will fail to reach many from socially deprived and ethnically diverse communities who are most at risk. This issue will have to be addressed if the Government’s vascular risk assessment programme is to achieve its aims.
“The BHF is disappointed that Nice ducked the issue of providing guidance on target levels of cholesterol for people who don’t yet have heart disease but are at high risk.” (Source: Pharmalot)